Evidence map›Paper›PMID 41992303›Full record

ArticleJournal of nanobiotechnology2026

The stimuli-responsive CRISPR-Cas12a system for modulating the selective aggregation of cell membrane receptors.

Ya Wang, Yujing Guo, Yamin Xiong, Xinyi Ren, Yunli Zhao, Lulu Song, Leiliang He

Abstract read
In one paragraph

Article in Journal of nanobiotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ya WangCollege of Public Health, Zhengzhou University, No.100 Science Avenue, Zhengzhou, 450001, China.
Yujing GuoCollege of Public Health, Zhengzhou University, No.100 Science Avenue, Zhengzhou, 450001, China.
Yamin XiongSchool of Life Sciences, Zhengzhou University, No.100 Science Avenue, Zhengzhou, 450001, China.
Xinyi RenCollege of Public Health, Zhengzhou University, No.100 Science Avenue, Zhengzhou, 450001, China.
Yunli ZhaoCollege of Public Health, Zhengzhou University, No.100 Science Avenue, Zhengzhou, 450001, China.
Lulu SongCollege of Public Health, Zhengzhou University, No.100 Science Avenue, Zhengzhou, 450001, China.
Leiliang HeCollege of Public Health, Zhengzhou University, No.100 Science Avenue, Zhengzhou, 450001, China. hell2015@zzu.edu.cn.

Funding

National Natural Science Foundation of China 82373630the training grant of Henan Province for Young Teachers 2023GGJS009
6 · The paper itself

Abstract

While CRISPR systems exhibit remarkable programmability in the field of nucleic acid editing, their extension to protein engineering faces a fundamental challenge, namely the traditional CRISPR tools lack the design to efficiently convert stimulus signals into the selective clustering of membrane receptors. This study develops a stimulus-responsive membrane-confined CRISPR-Cas12a platform that enhances selective clustering of membrane receptors for functional regulation. Specifically, a membrane-anchored DNA tetrahedral framework (TD-apt) was designed, which leverages vascular endothelial growth factor (VEGF) to activate Cas12a. Compared with unconfined CRISPR-Cas12a, membrane-confined CRISPR-Cas12a exhibits stronger cleavage activity, the interaction between the cellular-mesenchymal epithelial transition factor (c-Met) receptor and transferrin receptor (TfR) on A549 cells was efficiently modulated by nucleic acid assembly. This manipulation selectively inhibited c-Met function through spatial steric hindrance of TfR, modulating cellular behavior. Notably, the system's generality was validated by engineering of c-Met homodimerization for activation. This cascading regulatory paradigm of environmental sensing (VEGF response)-nucleic acid computation (CRISPR-based nucleic acid molecular computation)-protein assembly (receptor topological remodeling) effectively extends CRISPR's application boundaries to the field of non-genetic regulation protein-protein interaction (PPI) and establishes a versatile toolkit for dynamic and precise functional regulation.

Indexed as

CRISPR-Cas SystemsReceptors, Cell SurfaceReceptors, TransferrinA549 CellsHumansProto-Oncogene Proteins c-metVascular Endothelial Growth Factor AProto-Oncogene Proteins c-metReceptors, Cell SurfaceReceptors, TransferrinVascular Endothelial Growth Factor AAptamerCRISPR-Cas12aProtein-protein interactionsReceptorsStimuli-response

Identifiers

PMID41992303
PMCPMC13217656

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.